Retatrutide Steady State Chart: Week-by-Week Accumulation

What "Steady State" Means for Retatrutide

Steady state is the point where the drug absorbed from each weekly injection equals the drug cleared between doses. Once you hit it, plasma levels stop climbing and settle into a stable weekly rhythm of peaks and troughs. Before you hit it, every injection adds to a still-rising baseline. For retatrutide, reaching that plateau takes 4 to 5 weeks of weekly dosing at each dose level.

This is a different question from half-life. Half-life describes how fast the drug leaves once you stop. Steady state describes how it stacks up while you keep dosing. Same pharmacokinetics, opposite direction. So if you are on week 2 of a new dose and wondering whether it is working yet, you are not at full effect yet. Your level is still on its way up.

The 4-to-5-Half-Life Rule: How the PK Works

Pharmacokinetics has a simple rule: any drug taken on a fixed schedule reaches steady state after 4 to 5 half-lives, no matter what the compound is. Retatrutide's half-life is approximately 6 days. Four half-lives is 24 days, a little under 3.5 weeks. Five half-lives is 30 days, roughly 4.5 weeks. That arithmetic is where the 4-to-5-week window comes from: it falls straight out of the half-life the trial established.

Why This Is Not Arbitrary: It Shapes the 4-Week Titration Hold

The Phase 2 trial (Jastreboff et al., NEJM 2023) held each dose for 4 weeks before escalating. That interval maps onto the time a dose needs to reach plateau. Escalating before week 4 means stacking a higher dose on top of levels that are still rising from the previous one, which makes it nearly impossible to tell which dose is responsible for what you feel. Holding for 4 weeks lets each dose finish accumulating first. The retatrutide dosing guide walks through why each 4-week hold aligns with this timing.

Retatrutide Steady State Chart: Week by Week

The table below shows the approximate cumulative drug level as a percentage of the final plateau across the first six weeks of dosing at a single dose level. The numbers come from the standard exponential accumulation model applied to retatrutide's approximately 6-day half-life. They describe the shape of the build-up, nothing about weight outcomes.

How to Read This Chart

"Percentage of plateau" is a practical proxy for how much of a dose's effect is in play. At week 4, you are at roughly 96% of the appetite signaling, metabolic activity, and side effect profile you will experience at that dose. The last few percent compound slowly across the following weeks, but the clinical difference between 96% and 100% is small. This is the reasoning behind a prescriber starting to assess a dose around week 4 rather than week 1 or 2.

The Accumulation Chart vs. the Titration Chart

These two charts answer different questions, and it is easy to conflate them. A titration chart tells you which dose to take each week as you escalate from 2mg up to 12mg. This accumulation chart tells you how drug levels build within a single dose level before they level off. Both matter. For the week-by-week escalation schedule itself, see the retatrutide dosage chart and the more detailed retatrutide titration schedule.

Steady State at Each Dose Level: The Full Timeline

The accumulation chart above describes a single dose level. The standard titration moves through four of them. Here is how steady state lands across the complete arc from 2mg up to 12mg, holding each dose for 4 weeks.

These timings follow the standard titration (2mg, then 4mg, then 8mg, then 12mg, every 4 weeks) combined with the 4-to-5-week steady-state rule. Your doctor may move faster or slower depending on tolerability.

What Happens to Drug Levels When You Escalate

Stepping from 2mg to 4mg does not reset the accumulation clock to zero. The residual level from the 2mg weeks carries forward, and the new 4mg dose builds on top of it. In practice some people notice a faster onset at the 4mg step than they did at 2mg because of that carry-forward. The flip side is worth remembering too: if the first week or two of a new dose feels rough, your level is still below plateau. Give the full 4 weeks before drawing conclusions about how a dose suits you.

Does Steady State Change at Higher Doses?

No. Retatrutide's pharmacokinetics are dose-proportional (Urva et al., Lancet 2022), which means the approximately 6-day half-life holds across the full tested range of 0.5mg to 12mg. The accumulation curve has the same shape at 2mg, 4mg, 8mg, and 12mg. Only the ceiling, the absolute plasma level at plateau, changes. The time it takes to get there does not.

What Steady State Means for You

The accumulation curve changes three real decisions on retatrutide.

When to judge a dose. Not before week 4 at a given level. Judging a dose in week 1 or 2 means judging an incomplete drug level. The dose has not finished arriving yet.

When to expect the full side effect profile. Gastrointestinal effects such as nausea and diarrhea tend to peak in weeks 1 to 3 at a new dose and ease as the body adapts. But during that window the dose is also still below plateau, so the complete tolerability picture for a given dose is not clear until week 4 or 5.

When to consider escalating. The standard protocol escalates every 4 weeks, lined up exactly with the steady-state timeline. Escalating sooner means moving on before the current dose has had a fair evaluation.

Switching Doses: What Changes

When a dose changes, up or down, the old level starts clearing while the new one accumulates. For roughly 2 to 3 weeks the two overlap and drug levels are in flux. That overlap is why side effect patterns can feel unpredictable in the first few weeks after any dose change. It settles once the new level reaches its own plateau.

Missed Doses and Steady State

A missed dose disrupts steady state temporarily. Over the extra week without an injection, levels fall well below the normal trough, following the same exponential math as the accumulation table above. Re-establishing the plateau after you resume takes about 1 to 2 weeks, not the full initial 4 to 5, because residual drug is still in your system. You do not need to restart the 4-week evaluation window from scratch after a single miss. Two or more consecutive misses cause a larger drop and a longer rebuild. For how levels fall once you stop entirely, the retatrutide half-life guide covers the decay curve in detail.

How the Retatrutide Steady State Chart Compares to Tirzepatide and Semaglutide

All three of the major weekly compounds reach steady state within roughly a month, even though their half-lives differ slightly.

• Retatrutide: approximately 6-day half-life, an estimated 4 to 5 weeks to steady state (no label; derived from the half-life).
• Tirzepatide: approximately 5-day half-life, about 4 weeks to steady state (Zepbound and Mounjaro labels).
• Semaglutide: approximately 7-day half-life, 4 to 5 weeks to steady state (Ozempic label).

The reason they converge is the 4-to-5-half-life rule. What matters for the timeline is not the absolute half-life but its ratio to the dosing interval. All three are dosed weekly and all three sit in the 5-to-7-day half-life band, so they land on similar plateau timing of roughly a month. This is a cross-study observation, not a head-to-head trial. For the efficacy comparison, see the retatrutide vs tirzepatide guide. If you want the first-principles version of all this, the pharmacokinetics guide covers accumulation and clearance from the ground up.